How to apply for support

in page functions
[French]

Eligible countries can apply for new and underused vaccine (NVS) or cold chain equipment (CCE) Optimisation Platform support by submitting an application through the country portal

Countries requesting Health System Strengthening (HSS) support in 2017 (whether as a standalone or with NVS or CCE Optimisation Platform support) should contact their Gavi Senior Country Manager (SCM) for further information on the new process. Detailed guidance will be made available in early 2017.

HOW TO APPLY – PROCESS FOR REQUESTING NVS AND/OR CCEOP SUPPORT

  1. Country develops an application  
  2. The country develops an application for NVS or CCE Optimisation Platform support based on its national health plan. Applications for NVS support are submitted through Gavi’s online country portal, whilst applications for CCE Optimisation Platform support are submitted to proposals@gavi.org  

  3. IRC reviews application  
  4. Applications for both NVS and CCE Optimisation Platform support are reviewed by the Independent Review Committee (IRC). The IRC makes a recommendation to Gavi either to approve the application or to request the country to rework and resubmit it.

  5. Gavi approves application: vaccines or funds sent to country  

Gavi approves the IRC recommendations and the funds or vaccines are sent to the country. Once the programme starts, the country is required to regularly submit monitoring and reporting data to Gavi in order to renew support on a yearly basis.

WHEN TO APPLY FOR NVS AND/OR CCEOP SUPPORT

Applications will be accepted on a rolling basis. If a country misses a deadline, the application will be reviewed by the subsequent Independent Review Committee.

 

Round 1

Round 2

Round 3

Deadline for application submission  

18 January 2017

3 May 2017

8 September 2017

Application review dates (Independent Review Committee)  

13-24 March 2017*

14-23 June 2017

3-17 November 2017

Gavi decision  

by June 2017

by November 2017

by March 2018

* Dates modified after the Gavi General Guidelines have been issued.  

Countries are eligible to apply when their gross national income (GNI) per capita is below or equal to US$1,580, on a three-year rolling average (according to World Bank data issued in July each year). Find out more about Gavi's eligibility policy.

HOW TO APPLY – INSTRUCTIONS FOR NVS AND/OR CCEOP SUPPORT

Countries must submit applications for NVS applications through Gavi’s online country portal, which will open two months ahead of submission deadlines. Log in details will be provided directly to each country’s focal point.

Countries must submit applications for CCE Optimisation Platform support to proposals@gavi.org. Applications must be received by Gavi before the application deadline.

To guide their 2017 applications, countries must download the zip file containing the full application guidelines package (See APPLICATION DOCUMENTS below). These guidelines should be read in the following order (see flow chart for process details):

  1. General Guidelines  
  2. Support-specific Guidelines (applicable for CCE Optimisation Platform, Measles and Rubella and, from January 2017, HPV)
  3. Summary Product Profiles (applicable for each type of vaccine support)
  4. Application form  

APPLICATION DOCUMENTS

Click on the zip files below to download the full package of guidelines for each type of Gavi support. Alternatively, download individual documents using the table.

Type of support

Application guidelines package

Documents contained in the package

HPV vaccine  

download the document[English]
[French]
[Spanish]
[Russian]  
  • General Guidelines
  • HPV Specific Guidelines
  • Stakeholder Roles
  • Region Profile
  • Budgeting and Planning template
  • Budgeting and Planning template – User Guide
  • Summary Product Profile
  • FAQs
 

Japanese encephalitis vaccine  

download the document

[English]  

  • General Guidelines
  • Summary Product Profile
  • Budget Template
  • Budget Template User Guide
  • FAQs
 

Measles and Rubella vaccine  

download the document

[English]
[French]  

  • General Guidelines
  • Measles and Rubella Specific Guidelines
  • Summary Product Profile
  • Budget Template
  • Budget Template User Guide
  • FAQs
 

Meningitis A conjugate vaccine  

download the document

[English]
[French]  

  • General Guidelines
  • Summary Product Profile
  • Budget Template
  • Budget Template User Guide
  • FAQs
 

Pneumococcal vaccine  

download the document

[English]
[French]
[Russian]  

  • General Guidelines
  • Summary Product Profile
  • Budget Template (English & French only)
  • Budget Template User Guide (English & French only)
  • FAQs
 

Rotavirus vaccine  

download the document

[English]
[French]
[Russian]  

  • General Guidelines
  • Summary Product Profile
  • Budget Template (English & French only)
  • Budget Template User Guide (English & French only)
  • FAQs
 

Yellow fever vaccine  

download the document

[English]
[French]  

  • General Guidelines
  • Summary Product Profile
  • Budget Template
  • Budget Template User Guide
  • FAQs
 

Cold Chain Equipment Optimisation Platform  

download the document[English]
[French]
[Spanish]
[Russian]  
  • General Guidelines
  • CCE Optimisation Platform Specific Guidelines
  • CCE Optimisation Platform Application Form
 

Independent Review Committee review criteria

Download the criteria which the IRC uses to review applications for NVS or CCEOP support.

Review criteria tailored to the relevant type of support are also provided in the General Guidelines and each of the support-specific guidelines.

[English][French][Spanish][Russian]  

ACCESS TO PCV FOR COUNTRIES IN ACCELERATED TRANSITION OR TRANSITIONED OUT OF GAVI SUPPORT

Countries that (a) have crossed the eligibility threshold and completed their grace year; or (b) have completely transitioned out of Gavi support, and in either case are not yet approved for pneumococcal vaccine support, will continue to be able to apply for pneumococcal vaccines through Gavi under the terms and conditions of the Advance Market Commitment (AMC). As of January 2017, countries that have passed the eligibility threshold but have not yet applied for pneumococcal vaccine support are as follows: Bhutan, Cuba, Indonesia, Sri Lanka, Timor-Leste, and Vietnam.

Who to contact

For any questions regarding the application guidelines please contact countryportal@gavi.org or the Gavi Senior Country Manager.

 

Country portal

Learn more about Gavi’s online country portal 

NEW Cold chain equipment technology guide

How to choose cold chain solutions that match your country needs.

Download the document 

>200

Gavi supported over 200 vaccine introductions and campaigns in the 2011–2015 period – four times as many as in the previous five years.

Gavi

More facts...

close icon

modal window here